MCM
JAZZ icon

MAI Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

MAI Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$285K Buy
1,507
+1,289
+591% +$225K ﹤0.01% 1302
2025
Q4 		$37.1K Buy
218
+61
+39% +$9.35K ﹤0.01% 2186
2025
Q3 		$20.7K Buy
157
+22
+16% +$2.64K ﹤0.01% 2389
2025
Q2 		$14.3K Buy
135
+70
+108% +$7.6K ﹤0.01% 2534
2025
Q1 		$8.07K Sell
65
-197
-75% -$25.7K ﹤0.01% 2573
2024
Q4 		$32.3K Buy
+262
New +$30.9K ﹤0.01% 1993
2020
Q2 		– Sell
-4,998
Closed -$499K – 563
2020
Q1 		$499K Buy
4,998
+275
+6% +$35.6K 0.02% 361
2019
Q4 		$705K Sell
4,723
-61
-1% -$8.3K 0.02% 348
2019
Q3 		$613K Buy
4,784
+420
+10% +$56.3K 0.03% 325
2019
Q2 		$622K Buy
4,364
+96
+2% +$12.9K 0.03% 317
2019
Q1 		$610K Sell
4,268
-300
-7% -$39.1K 0.03% 277
2018
Q4 		$566K Sell
4,568
-64
-1% -$9.49K 0.03% 285
2018
Q3 		$779K Sell
4,632
-241
-5% -$41.4K 0.04% 265
2018
Q2 		$840K Buy
+4,873
New +$797K 0.05% 238

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

MAI Capital Management's JAZZ Position: Q1 2026 in Review

MAI Capital Management increased its Jazz Pharmaceuticals (JAZZ) stake by 591% in Q1 2026, buying an estimated $225K and bringing the position to 1,507 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #1302.

MAI Capital Management first reported a position in JAZZ in Q2 2018 and has held it in 14 quarters since. The position peaked at $840K in Q2 2018. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • MAI Capital Management held 1,507 shares of Jazz Pharmaceuticals worth $285K as of Q1 2026.
  • MAI Capital Management bought 1,289 Jazz Pharmaceuticals shares in Q1 2026, an estimated $225K.
  • Jazz Pharmaceuticals made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #1302 holding.
  • MAI Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2018 and has held it in 14 quarters since.
  • MAI Capital Management's Jazz Pharmaceuticals position peaked at $840K in Q2 2018.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.